|
|
- 2017
Tolerability of ORM-12741 and effects on episodic memory in patients with Alzheimer's diseaseDOI: 10.1016/j.trci.2016.11.004 Keywords: Alzheimer's disease, Cognition, Memory, Alpha-2C adrenoceptor antagonist, ORM-12741, Randomized trials, Behavioral and psychological symptoms of dementia, Neuropsychiatric symptoms Abstract: ORM-12741 is a novel selective antagonist of alpha-2C adrenoceptors. This trial evaluated the safety and efficacy of ORM-12741 in patients with Alzheimer's disease (AD)
|
